Intellia Therapeutics Names Glenn Goddard as New Chief Financial Officer

Go back to Intellia Therapeutics Names Glenn Goddard as New Chief Financial Officer
(NASDAQ: NTLA) Delayed: 12.76 +0.07 (0.55%)
Previous Close $12.69    52 Week High $30.40 
Open $12.67    52 Week Low $11.86 
Day High $13.13    P/E N/A 
Day Low $12.28    EPS $0.00 
Volume 3,245,362